Cartesse IVD™ will be a cartilage biomaterial implant in the shape of an intervertebral disc (IVD) spacer. Cartesse IVD™ will feel and function like real IVD cartilage and aim to restore the height and function of the IVD without requiring spinal fusion.
Over 450,000 spinal fusions are performed each year to treat IVD damage and degeneration at a cost of more than $12B per year. However, loss of mobility, continued pain, and fusion failure rates remain problematic for patients with spinal fusion procedures. Whereas many technologies focus on improving bone fusion, Cartesse IVD™ is the biomaterial solution that will eliminate the need for spinal fusion procedures.